Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Invention for Innovation Dementia Stage 1 Minutes


Published: 25 April 2022

Version: 1 - April 2022

Print this document

Minutes of the Invention for Innovation (i4i) Programme Sub-Committee Meeting to discuss applications to Dementia Stage 1

Date and Location 

Meeting held on on Thursday 3rd February 2022 via Zoom Virtual Meeting 

In attendance 

Prof David Llewellyn (Chair)
Professor Blossom Stephan (Deputy Chair) 

i4i Secretariat

Professor Mike Lewis (Programme Director)
Dr Ruth Nebauer (Assistant Director)
Dr Andrew Barber
Ami Hodges
Mrs Paula Milton
Mr Edwin Tucker
Dr Xi Ye


Dr Anni Bailey (DHSC)
Caroline de Winter (NIHR Operations)

The following Stage 1 applications were discussed by the Sub-Committee and invited to progress to Stage 2

NIHR204279: Diagnosing dementia using Fastball neurocognitive assessment
Outcome: Invited to Stage 2

NIHR204280: Digital assessment of auditory perception in dementia (DIADEM)
Outcome: Invited to Stage 2

NIHR204283: Spatial biomarkers of early Alzheimer's disease (SABRE)
Outcome: Invited to Stage 2 

NIHR204284: Clinical validation and commercialisation of the ReaCTIVE app: A proactive, interactive cognitive monitoring and intervention solution for people with early cognitive impairment
Outcome: Invited to Stage 2

NIHR204286: Detecting and monitoring dementia using dynamic digital biomarkers of night-time behaviour
Outcome: Invited to Stage 2

NIHR204289: Remote monitoring and early diagnosis in patients with Mild Cognitive Impairment in the community (ReMCI)
Outcome: Invited to Stage 2

NIHR204290: Identifying older patients at high short-term risk of dementia and cognitive decline using routinely collected hospital electronic clinical and brain imaging data to improve care
Outcome: Invited to Stage 2

Stage 1 applications not invited to submit to Stage 2:

NIHR204277: Development of a digital device application for future dementia risk estimation: A validation study
Outcome: Reject

NIHR204278: AI-derived Parkinson's Disease Dementia stratification tool to identify at-risk individuals for monitoring, personalised care plans and focused drug clinical trials
Outcome: Reject

NIHR204281: STRATification of people with cognitive Impairment using EEG (STRATEEG)
Outcome: Reject

NIHR204282: Pupil light response and saccadic eye movement in dementia
Outcome:  Reject

NIHR204285: An Eye for Dementia
Outcome: Reject

NIHR204287: Developing and validating a GP-led infrastructure for digitally-based early dementia diagnosis
Outcome: Reject

NIHR204288: Gait evalUation as an Indicator of DEmentia subtypes study (GUIDE)
Outcome: Reject